Venlafaxine XR Product Recall (2019-12-20)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
Venlafaxine XR 37.5 mg Capsule
| Lot or serial number | Brand name | Companies | DIN, NPN, DIN-HIM | Dosage form | Strength |
|---|
| W07930 | B. Teva-Venlafaxine XR 150 mg Capsule | - Recalling Firm
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
- Marketing Authorization Holder
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
| DIN 02275058 | Capsule (Extended Release) | Venlafaxine hydrochloride 150 mg |
| W05930 | Venlafaxine XR 37.5 mg Capsule | - Recalling Firm
- Sanis Health
- 243 Consumers Road
- Toronto
- M2J 4W8
- Ontario
- CANADA
- Marketing Authorization Holder
- Sanis Health
- 243 Consumers Road
- Toronto
- M2J 4W8
- Ontario
- CANADA
| DIN 02354713 | Capsule (Extended Release) | Venlafaxine hydrochloride 37.5 mg |
-
Venlafaxine XR 37.5 mg Capsule
-
Teva-Venlafaxine XR 150 mg Capsule
The dissolution is out of trend in the affected lot.
Healthcare Establishments, Retailers